Category Health/Medical

Scientists at Duke-NUS Medical School have identified how the first domino falls after a person encounters an allergen, such as peanuts, shellfish, pollen or dustmites. Their discovery, published in the April issue of Nature Immunology, could herald the development of drugs to prevent these severe reactions.

It is well established that when mast cells, a type of immune cell, mistake a harmless substance, such as peanuts or dust mites, as a threat, they release an immediate first wave of bioactive chemicals against the perceived threat...

An international team led by researchers at the University of Toronto has found a new RNA virus that they believe is h...

An immunotherapy drug given before surgery instead of chemotherapy meant that over ten times more patients with a certain genetic profile were cancer-free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.

The findings, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024, are interim results from the NEOPRISM-CRC phase II clinical trial assessing whether the immunotherapy drug pembrolizumab can improve outcomes for patients with stage two or stage three MMR deficient/MSI-High bowel cancer. The trial was a collaboration among UCL, UCLH, the Christie NHS Foundation Trust in Manchester, St...

A novel medical advancement termed the “sticky and strain-gradient artificial epineurium” (SSGAE) has been developed, demonstrating remarkable efficacy in rapidly healing severed nerves without traditional microsurgical suturing techniques.

This innovation, spearheaded by a collaborative effort between Professor Jong Woong Park from Orthopedic Surgery, Korea University College of Medicine, Professor Donghee Son from Sungkyunkwan University Department of Superintelligence Engineering, and Professor Mikyung Shin from the Department of Biomedical Engineering, presents a significant breakthrough in nerve repair surge...